Department of Radiology
Found 13 results
Filters: Author is Cheung, Nai-Kong V  [Clear All Filters]
2023
Chung SK, Vargas DBurnes, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B et al..  2023.  Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.. J Nucl Med. 64(9):1439-1445.
Kurtz K, Eibler L, Dacek MM, Carter LM, Veach DR, Lovibond S, Reynaud E, Qureshy S, McDevitt MR, Bourne C et al..  2023.  Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.. Theranostics. 13(15):5469-5482.
2021
Cheal SM, Patel M, Yang G, Veach DR, Xu H, Guo H-F, Zanzonico PB, Axworthy DB, Cheung N-KV, Ouerfelli O et al..  2021.  Correction to An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.. Bioconjug Chem. 32(2):394.
Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, Vargas DBurnes, Kubik TZ, Monette S, Santich BH et al..  2021.  Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications.. Bioconjug Chem. 32(4):649-654.
Yerrabelli RS, He P, Fung EK, Kramer K, Zanzonico PB, Humm JL, Guo H, Pandit-Taskar N, Larson SM, Cheung N-KV.  2021.  IntraOmmaya compartmental radioimmunotherapy using I-omburtamab-pharmacokinetic modeling to optimize therapeutic index.. Eur J Nucl Med Mol Imaging. 48(4):1166-1177.
2020
Cheal SM, Patel M, Yang G, Veach D, Xu H, Guo H-F, Zanzonico PB, Axworthy DB, Cheung N-KV, Ouerfelli O et al..  2020.  An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.. Bioconjug Chem. 31(3):501-506.
Cheal SM, McDevitt MR, Santich BH, Patel M, Yang G, Fung EK, Veach DR, Bell M, Ahad A, Vargas DBurnes et al..  2020.  Alpha radioimmunotherapy using Ac-proteus-DOTA for solid tumors - safety at curative doses.. Theranostics. 10(25):11359-11375.
2019
Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, Zhang Z, Lyashchenko SK, Fung AM, Pentlow KS et al..  2019.  Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.. J Nucl Med. 60(12):1794-1801.
2018
Cheal SM, Xu H, Guo H-F, Patel M, Punzalan B, Fung EK, Lee S-G, Bell M, Singh M, Jungbluth AA et al..  2018.  Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.. Theranostics. 8(18):5106-5125.
2017
Cheal SM, Fung EK, Patel M, Xu H, Guo H-F, Zanzonico PB, Monette S, K Wittrup D, Cheung N-KV, Larson SM.  2017.  Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.. J Nucl Med. 58(11):1735-1742.
2016
Cheal SM, Xu H, Guo H-F, Lee S-G, Punzalan B, Chalasani S, Fung EK, Jungbluth A, Zanzonico PB, Carrasquillo JA et al..  2016.  Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.. Eur J Nucl Med Mol Imaging. 43(5):925-937.
2015
Ahmed M, Cheng M, Zhao Q, Goldgur Y, Cheal SM, Guo H-F, Larson SM, Cheung N-KV.  2015.  Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.. J Biol Chem. 290(50):30018-29.
2008
Luther N, Cheung N-KV, Dunkel IJ, Fraser JF, Edgar MA, Gutin PH, Souweidane MM.  2008.  Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9.. Neurosurgery. 63(6):1166-74;discussion1174.